Pancreatic Cancer Research

ResearcherArmy Medical UniversityActive in the last 2 years

Jian Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0212-4464; OpenAlex author ID A5100402562. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 4

  1. Disulfidptosis: a novel gene-based signature predicts prognosis and immunotherapy efficacy of pancreatic adenocarcinoma. First author DOI 10.1007/s12672-025-02053-w↗
  2. Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma. Co-author DOI 10.1186/s12935-022-02836-z↗
  3. N6-methyladenosine (m6A) in pancreatic cancer: Regulatory mechanisms and future direction. Co-author DOI 10.7150/ijbs.60115↗
  4. Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1/2 signaling pathway. Co-author DOI 10.1016/j.canlet.2017.03.014↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huaizhi Wang · 4 shared papers, 2017–2025 · strength 0.90
  2. Jingyang Yin · 2 shared papers, 2023–2025 · strength 0.66
  3. Bing Ni · 3 shared papers, 2017–2023 · strength 0.48
  4. Wenhua Li · 1 shared paper, 2023 · strength 0.24
  5. Yongkang Liu · 1 shared paper, 2021 · strength 0.17
  6. Yu You · 1 shared paper, 2017 · strength 0.07
  7. Zhiping Zhao · 1 shared paper, 2017 · strength 0.07
  8. Ping Bie · 1 shared paper, 2017 · strength 0.07
  9. Xuejun Xu · 1 shared paper, 2017 · strength 0.07
  10. Shixiang Guo · 1 shared paper, 2017 · strength 0.07
  11. Songsong Liu · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.